EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tau PET Imaging With [ 18 F ] MK ‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease

Thomas Gérard iD, Lise Colmant iD, Vincent Malotaux iD, Yasmine Salman iD, Lara Huyghe iD, Lisa Quenon iD, Emilien Boyer iD, Laurence Dricot iD, Adrian Ivanoiu, Renaud Lhommel iD, Bernard Hanseeuw iD

European Journal of Neurology · 2025

DOI: 10.1111/ene.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Thomas Gérard und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Cliniques Universitaires Saint Luc, Brussels, Belgium. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Alzheimer Disease, Tauopathies, tau Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de la Recherche Scientifique - FNRS, WelBio, StopAlzheimer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Second‐generation tau‐PET tracers like [ 18 F]MK‐6240 are increasingly used both for diagnosing and quantifying Alzheimer's Disease (AD) tauopathy. However, while [ 18 F]MK‐6240 tau‐PET has demonstrated excellent sensitivity for AD tauopathy, data assessing its specificity and binding in non‐AD tauopathies are still scarce.

Methods

Participants were assigned to exclusive categorical diagnoses based on their amyloid (Aβ) and cognitive status. We quantified mesiotemporal (MTL) and neocortical [ 18 F]MK‐6240 tau‐PET signal in 28 Aβ− cognitively impaired (CI) patients presenting various non‐AD neurodegenerative disorders. Tau‐PET quantifications were compared with Aβ− cognitively unimpaired (CU) subjects ( n = 51) and Aβ+ CI patients ( n = 77).

Results

Among the 28 Aβ− impaired subjects, only five presented significant and isolated mesiotemporal signal, most of them being suspected of primary age‐related tauopathy (PART). Only two Aβ− impaired patients (7%) presented positive neocortical signal, both being diagnosed with fronto‐temporal degeneration (FTD). The Tau‐PET results of all the remaining Aβ− patients were comparable to the CU population, including eight other FTD patients. Importantly, 4R‐only tauopathies (CBD and PSP) and sv‐PPA were negative. Conclusion [ 18 F]MK‐6240 tau‐PET has a special affinity for tauopathies involving 3R/4R paired helical filaments: AD, PART (Aβ− subjects with MTL‐restricted tau‐PET signal) and some forms of FTD while most primary tauopathies do not exhibit significant cortical signal. Positive neocortical scans are therefore highly specific for AD tauopathy. Based on those and previous results, we propose a diagnostic flowchart for MCI subjects suspected of AD or another tauopathy which may significantly reduce the need for amyloid PET or CSF measurement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyAlzheimer DiseaseTauopathiestau ProteinsBrainHumansMaleFemaleAgedMiddle AgedSensitivity and SpecificityAged, 80 and overFluorine RadioisotopesRadiopharmaceuticalsCognitive DysfunctionIsoquinolines

Stichwörter der Autor:innen

Alzheimer's diseaseMK‐6240Tau PETneurodegenerative diseasestauopathy

Substanzen

tau ProteinsMK-6240Fluorine RadioisotopesRadiopharmaceuticalsIsoquinolines

Autor:innen und Institutionen

  • Nuclear Medicine Department, Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • Institute of Neurosciences, Université Catholique de Louvain, Brussels, Belgium.
  • Neurology Department, Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • WELBIO Department, WEL Research Institute, Wavre, Belgium.
  • Department of Radiology, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Thomas Gérard, Lise Colmant, Vincent Malotaux, Yasmine Salman, Lara Huyghe, Lisa Quenon, Emilien Boyer, Laurence Dricot, Renaud Lhommel, Bernard Hanseeuw

Förderung

  • Fonds de la Recherche Scientifique - FNRS
  • WelBio
  • StopAlzheimer Foundation
  • Walloon excellence in life sciences and biotechnology

Zitieren

APA

Gérard, T., Colmant, L., Malotaux, V., Salman, Y., Huyghe, L., Quenon, L., Boyer, E., Dricot, L., Ivanoiu, A., Lhommel, R., & Hanseeuw, B. (2025). Tau PET Imaging With [ 18 F ] MK ‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease. European Journal of Neurology. https://doi.org/10.1111/ene.70068

Vancouver

Gérard T, Colmant L, Malotaux V, Salman Y, Huyghe L, Quenon L, et al. Tau PET Imaging With [ 18 F ] MK ‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease. European Journal of Neurology. 2025. doi:10.1111/ene.70068

BibTeX
@article{Grard2025,
  author = {Gérard, Thomas and Colmant, Lise and Malotaux, Vincent and Salman, Yasmine and Huyghe, Lara and Quenon, Lisa and Boyer, Emilien and Dricot, Laurence and Ivanoiu, Adrian and Lhommel, Renaud and Hanseeuw, Bernard},
  title = {Tau PET Imaging With [ 18 F ] MK ‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70068}
}
Kostenlos starten →